FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980974790> ?p ?o ?g. }

• W1980974790 endingPage "2918" @default.
• W1980974790 startingPage "2908" @default.
• W1980974790 abstract "Predictors of treatment resistance and relapse have been identified in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis in the Glomerular Disease Collaborative Network (GDCN) in the southeastern US. This study was undertaken to evaluate the applicability of those predictors in an independent cohort followed up by the French Vasculitis Study Group.Predictors of treatment resistance were evaluated using logistic regression models and reported as odds ratios (ORs) with 95% confidence intervals (95% CIs). Predictors of relapse were evaluated using Cox proportional hazards models and reported as hazard ratios (HRs) with 95% CIs. Models were controlled for age, sex, race, baseline serum creatinine level, and cyclophosphamide therapy.The French cohort (n = 434) and the GDCN cohort (n = 350) had similar median followup periods (44 months versus 45 months) and initial percentages of patients taking cyclophosphamide (82% versus 78%). The French cohort included more patients with proteinase 3 (PR3) ANCA (58% versus 40%), lung involvement (58% versus 49%), and upper respiratory tract involvement (62% versus 31%). Of the predictors of treatment resistance in the GDCN cohort (female sex, African American race, presence of myeloperoxidase ANCA, elevated creatinine level, and age), only age predicted treatment resistance in the French cohort (OR 1.32 per 10 years [95% CI 1.05-1.66]). Predictors of relapse in the GDCN cohort were PR3 ANCA (HR 1.77 [95% CI 1.11-2.82]), lung involvement (HR 1.68 [95% CI 1.10-2.57), and upper respiratory tract involvement (HR 1.58 [95% CI 1.00-2.48]), while predictors in the French cohort were PR3 ANCA (HR 1.66 [95% CI 1.15-2.39]) and lung involvement (HR 1.56 [95% CI 1.11-2.20]), but not upper respiratory tract involvement (HR 0.96 [95% CI 0.67-1.38]).Our findings indicate that older age is a predictor of treatment resistance, and that PR3 ANCA and lung involvement are predictors of relapse in both cohorts. Discrepancies in predictors of treatment tract resistance may reflect differences in access to care, and differences in predictors of relapse may reflect variations in disease expression." @default.
• W1980974790 created "2016-06-24" @default.
• W1980974790 creator A5003827669 @default.
• W1980974790 creator A5007882790 @default.
• W1980974790 creator A5042064091 @default.
• W1980974790 creator A5066638505 @default.
• W1980974790 creator A5075309120 @default.
• W1980974790 creator A5082190748 @default.
• W1980974790 creator A5086851939 @default.
• W1980974790 date "2008-09-01" @default.
• W1980974790 modified "2023-10-11" @default.
• W1980974790 title "Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts" @default.
• W1980974790 cites W1570622790 @default.
• W1980974790 cites W1970456986 @default.
• W1980974790 cites W1983098471 @default.
• W1980974790 cites W1989119273 @default.
• W1980974790 cites W1989583983 @default.
• W1980974790 cites W1991708457 @default.
• W1980974790 cites W2006899677 @default.
• W1980974790 cites W2022541722 @default.
• W1980974790 cites W2041565487 @default.
• W1980974790 cites W2043940516 @default.
• W1980974790 cites W2044732270 @default.
• W1980974790 cites W2053452241 @default.
• W1980974790 cites W2055253085 @default.
• W1980974790 cites W2055896786 @default.
• W1980974790 cites W2061293215 @default.
• W1980974790 cites W2069113872 @default.
• W1980974790 cites W2079613972 @default.
• W1980974790 cites W2099706141 @default.
• W1980974790 cites W2108789073 @default.
• W1980974790 cites W2123760012 @default.
• W1980974790 cites W2133688753 @default.
• W1980974790 cites W2134743399 @default.
• W1980974790 cites W2140547944 @default.
• W1980974790 cites W2150733859 @default.
• W1980974790 cites W2160041258 @default.
• W1980974790 cites W2264075806 @default.
• W1980974790 cites W2329069429 @default.
• W1980974790 cites W2473041787 @default.
• W1980974790 cites W2581458651 @default.
• W1980974790 cites W4253982444 @default.
• W1980974790 doi "https://doi.org/10.1002/art.23800" @default.
• W1980974790 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2754705" @default.
• W1980974790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18759282" @default.
• W1980974790 hasPublicationYear "2008" @default.
• W1980974790 type Work @default.
• W1980974790 sameAs 1980974790 @default.
• W1980974790 citedByCount "218" @default.
• W1980974790 countsByYear W19809747902012 @default.
• W1980974790 countsByYear W19809747902013 @default.
• W1980974790 countsByYear W19809747902014 @default.
• W1980974790 countsByYear W19809747902015 @default.
• W1980974790 countsByYear W19809747902016 @default.
• W1980974790 countsByYear W19809747902017 @default.
• W1980974790 countsByYear W19809747902018 @default.
• W1980974790 countsByYear W19809747902019 @default.
• W1980974790 countsByYear W19809747902020 @default.
• W1980974790 countsByYear W19809747902021 @default.
• W1980974790 countsByYear W19809747902022 @default.
• W1980974790 countsByYear W19809747902023 @default.
• W1980974790 crossrefType "journal-article" @default.
• W1980974790 hasAuthorship W1980974790A5003827669 @default.
• W1980974790 hasAuthorship W1980974790A5007882790 @default.
• W1980974790 hasAuthorship W1980974790A5042064091 @default.
• W1980974790 hasAuthorship W1980974790A5066638505 @default.
• W1980974790 hasAuthorship W1980974790A5075309120 @default.
• W1980974790 hasAuthorship W1980974790A5082190748 @default.
• W1980974790 hasAuthorship W1980974790A5086851939 @default.
• W1980974790 hasBestOaLocation W19809747901 @default.
• W1980974790 hasConcept C126322002 @default.
• W1980974790 hasConcept C156957248 @default.
• W1980974790 hasConcept C207103383 @default.
• W1980974790 hasConcept C24040308 @default.
• W1980974790 hasConcept C2776015282 @default.
• W1980974790 hasConcept C2776694085 @default.
• W1980974790 hasConcept C2776755627 @default.
• W1980974790 hasConcept C2779134260 @default.
• W1980974790 hasConcept C2780306776 @default.
• W1980974790 hasConcept C44249647 @default.
• W1980974790 hasConcept C50382708 @default.
• W1980974790 hasConcept C71924100 @default.
• W1980974790 hasConcept C72563966 @default.
• W1980974790 hasConcept C90924648 @default.
• W1980974790 hasConceptScore W1980974790C126322002 @default.
• W1980974790 hasConceptScore W1980974790C156957248 @default.
• W1980974790 hasConceptScore W1980974790C207103383 @default.
• W1980974790 hasConceptScore W1980974790C24040308 @default.
• W1980974790 hasConceptScore W1980974790C2776015282 @default.
• W1980974790 hasConceptScore W1980974790C2776694085 @default.
• W1980974790 hasConceptScore W1980974790C2776755627 @default.
• W1980974790 hasConceptScore W1980974790C2779134260 @default.
• W1980974790 hasConceptScore W1980974790C2780306776 @default.
• W1980974790 hasConceptScore W1980974790C44249647 @default.
• W1980974790 hasConceptScore W1980974790C50382708 @default.
• W1980974790 hasConceptScore W1980974790C71924100 @default.
• W1980974790 hasConceptScore W1980974790C72563966 @default.
• W1980974790 hasConceptScore W1980974790C90924648 @default.

• next